CB-103
CB-103 is a orally active inhibitor of notch signaling pathway, with anti-tumor activity. CB-103 has shown the ability to block NOTCH signaling in human T cell acute lymphoblastic leukemia cancer cell lines, and exhibits anti-tumor efficacy in GSI resistant T-ALL cell lines.
Product Specifications
CAS Number
218457-67-1
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
242.32
Molecular Formula
C15H18N2O
Notes
Research use only, not for human use.
Receptor
Notch
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C9095-45X-AP 200 µL
CYP4X1, NT (CYPIVX1, Cytochrome P450 4X1, UNQ1929/PRO4404) (AP) discontinued
Sign In for Pricing
View Details